$3.77
0.03[0.80%]
At close: Apr 19
$3.77
0[0.00%]
After Hours: 4:28PM EDT
Design Therapeutics
(NASDAQ:DSGN)Latest News for Design Therapeutics Stock (NASDAQ:DSGN)
Design Therapeutics Stock (NASDAQ: DSGN)
Categories: All
Tuesday, March 26, 2024
Wednesday, March 20, 2024
Tuesday, March 19, 2024
Monday, March 18, 2024
Friday, February 09, 2024
Tuesday, November 14, 2023
Monday, November 13, 2023
Thursday, September 07, 2023
Wednesday, September 06, 2023
Thursday, August 31, 2023
Tuesday, August 22, 2023
Thursday, August 17, 2023
Tuesday, August 15, 2023
- Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further DevelopmentsVandana Singh - Aug 15, 2023, 3:32PM
- Nasdaq Falls 100 Points; Siyata Mobile Shares Spike HigherLisa Levin - Aug 15, 2023, 3:04PM
- Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Aug 15, 2023, 2:01PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Aug 15, 2023, 1:31PM
- Crude Oil Down 2%; Home Depot Posts Upbeat EarningsLisa Levin - Aug 15, 2023, 12:00PM
- Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023Benzinga Insights - Aug 15, 2023, 11:00AM
- Dow Falls Over 200 Points; US Retail Sales Top ExpectationsLisa Levin - Aug 15, 2023, 10:01AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Aug 15, 2023, 9:06AM
- Why Is Design Therapeutics Stock Moving Lower Today?Vandana Singh - Aug 15, 2023, 9:04AM
- Design Therapeutics shares are trading lower after the company reported initial results from its Phase 1 multiple-ascending dose study of DT-216 for the treatment of Friedrich ataxia. The company said there were injection site reactions.Benzinga Newsdesk - Aug 15, 2023, 8:44AM
- Wedbush Downgrades Design Therapeutics to Neutral, Announces $6 Price TargetBenzinga Newsdesk - Aug 15, 2023, 8:27AM
- SVB Leerink Downgrades Design Therapeutics to Market Perform, Announces $6 Price TargetBenzinga Newsdesk - Aug 15, 2023, 8:18AM
- Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving PremarketLisa Levin - Aug 15, 2023, 8:17AM
- RBC Capital Downgrades Design Therapeutics to Sector Perform, Lowers Price Target to $7Benzinga Newsdesk - Aug 15, 2023, 8:09AM
- Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionLisa Levin - Aug 15, 2023, 7:00AM
Monday, August 14, 2023
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Aug 14, 2023, 5:32PM
- Design Therapeutics Q2 EPS $(0.36) Beats $(0.40) EstimateBenzinga Newsdesk - Aug 14, 2023, 4:34PM
- Design Therapeutics Reports Initial Results From Phase 1 Multiple-Ascending Dose Study Of DT-216 For The Treatment Of Friedrich AtaxiaBenzinga Newsdesk - Aug 14, 2023, 4:02PM
Friday, July 28, 2023
- Shares of companies with Friedrich's Ataxia candidates are trading higher after Biogen announced the acquisition of Reata.Benzinga Newsdesk - Jul 28, 2023, 12:42PM
- Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not AnticipatedVandana Singh - Jul 28, 2023, 11:56AM